HHMI
CTSH icon

Howard Hughes Medical Institute’s Cognizant CTSH Stock Holding History

Howard Hughes Medical Institute’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104
Closed -$8.63K – 143
2025
Q4 		$8.63K Sell
104
-1
-1% -$75 ﹤0.01% 237
2025
Q3 		$7.04K Sell
105
-1
-0.9% -$72 ﹤0.01% 273
2025
Q2 		$8.27K Buy
+106
New +$8.12K ﹤0.01% 234
2014
Q4 		– Sell
-2,971
Closed -$133K – 173
2014
Q3 		$133K Buy
+2,971
New +$140K 0.03% 134
2014
Q2 		– Sell
-8,470
Closed -$429K – 189
2014
Q1 		$429K Sell
8,470
-330
-4% -$16.5K 0.06% 52
2013
Q4 		$444K Sell
8,800
-742
-8% -$33.8K 0.07% 57
2013
Q3 		$392K Buy
9,542
+3,500
+58% +$130K 0.06% 64
2013
Q2 		$189K Buy
+6,042
New +$201K 0.06% 95

Other funds holding CTSH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Howard Hughes Medical Institute's CTSH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 104 shares — an estimated $8.63K sold.

Howard Hughes Medical Institute first reported a position in CTSH in Q2 2013 and held it in 8 quarters. The position peaked at $444K in Q4 2013. 993 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 104 Cognizant shares in Q1 2026, an estimated $8.63K.
  • Howard Hughes Medical Institute first reported a position in Cognizant in Q2 2013 and held it in 8 quarters.
  • Howard Hughes Medical Institute's Cognizant position peaked at $444K in Q4 2013.
  • 993 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.